Origin Therapeutics Announces Results of Annual General and Special Meeting of Shareholders
VANCOUVER, British Columbia, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (the “Company” or “Origin”) (CSE: ORIG) is pleased to announce that, in connection with the proposed business combination transaction (the “Transaction”) with Safe Supply Streaming Co Ltd. (“Safe Supply”), all matters submitted to shareholders for approval as set out in detail in the Company’s management information circular dated August 1, 2023 (“Circular”) were approved at the annual general and special meeting of the shareholders of the Company held on August 31, 2023 (the “Meeting”).